Many people with diabetes have the earliest stage of diabetic retinopathy, called mild nonproliferative diabetic retinopathy (NPDR), without even knowing it, according to the American Academy of ...

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...

Starting intravitreous aflibercept (Eylea, Regeneron) among patients with nonproliferative diabetic retinopathy (NPDR) without center-involved diabetic macular edema did not lead to better visual ...

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. EYP-1901 combines sustained delivery technology and ...

Adults with type 2 diabetes had a higher risk for diabetic retinopathy if they had a higher TSH level. The highest diabetic retinopathy risk was observed for adults with high TSH and a lower time in ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Specific changes to your eye’s blood vessels can indicate that you have an eye complication of diabetes that needs attention. When you have diabetes, especially for a long time, high blood sugar ...

The risk for nonproliferative diabetic retinopathy progression was similar for empagliflozin vs DPP4i therapy. (HealthDay News) — Empagliflozin initiation is not associated with incident ...

Diabetic retinopathy is an eye condition that causes changes to the blood vessels in the part of your eye called the retina. That's the lining at the back of your eye that changes light into images.